Regulatory & Legal

As governments mandate a shift to post-quantum cryptography, a new chip offers a hardware-based solution to secure everything from cars to national defense.

The tax giant is betting big on the $250B creator economy with a new platform. Can it solve the financial chaos plaguing today's digital entrepreneurs?

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

Insight Molecular Diagnostics secures $26M to expand its transplant rejection test to the heart market, backed by a major shareholder amid market dilution concerns.

A new social commerce platform lets you earn company equity by shopping for Nike and Adidas. Can it change how we shop and keep our fitness goals?

A new partnership with Uniphar will use managed access programs to provide the lymphoma therapy LYMPHIR to European patients with limited treatment options.

Sphinx Investment extends its takeover offer for Performance Shipping again, marking a nearly three-year saga of corporate warfare and shareholder uncertainty.

Aveanna Healthcare's Heartways program earns a top national certification, signaling a major shift in managing America's costliest disease from home.

Daré Bioscience launches telehealth for DARE to PLAY™, the first evidence-backed topical sildenafil cream designed to address female sexual arousal.

With a new finance chief and an expanded Austin base, Outdoorsy Group is pivoting its travel tech empire to power the coming age of autonomous mobility.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

Abaxx's new wind futures for the Netherlands, France, and Spain aim to provide critical financial tools to stabilize renewable energy revenue streams.

Gaming giant The9 is using generative AI to resurrect the iconic TVB drama 'The Greed of Man' as a short drama and an interactive movie game.

The defense contractor signals a strategic shift after lost contracts and procurement delays slash its 2027 revenue outlook, even as profits beat expectations.

Health Canada grants conditional approval to BioMarin's VOXZOGO, the first drug in the country to target the genetic cause of achondroplasia.

As OneSpaWorld prepares its Q4 results, all eyes are on the wellness giant as a barometer for luxury travel spending and its tech-driven future.

NervGen Pharma to unveil data showing its drug NVG-291 provides lasting functional gains for chronic spinal cord injury, a major step forward.

New research proves pocket-sized, AI-powered ultrasound is a game-changer for urgent care, tackling staff shortages and improving patient outcomes.

A new partnership between QuiX Quantum and Artilux aims to solve quantum computing's biggest hurdles: energy consumption and practical deployment.

A newly identified molecule, HOXD13, both fuels melanoma growth and shields it from the immune system, paving the way for a novel combination therapy.